- Home
- KLTR vs IVVD Comparison
KLTR vs IVVD Comparison
Compare KLTR & IVVD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | KLTR | IVVD |
|---|---|---|
| Founded | 2006 | 2020 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | EDP Services | Biotechnology: Pharmaceutical Preparations |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 199.8M | 212.6M |
| IPO Year | 2021 | 2021 |
Fundamental Metrics
Financial Performance| Metric | KLTR | IVVD |
|---|---|---|
| Price | $1.44 | $0.61 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 2 | 3 |
| Target Price | $3.50 | ★ $10.00 |
| AVG Volume (30 Days) | 193.4K | ★ 4.6M |
| Earning Date | 11-09-2026 | 11-05-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 61.90 | ★ 79.02 |
| EPS | ★ N/A | N/A |
| Revenue | ★ $180,854,000.00 | $53,426,000.00 |
| Revenue This Year | $1.74 | $12.40 |
| Revenue Next Year | $4.18 | $44.85 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | 1.20 | ★ 110.47 |
| 52 Week Low | $1.06 | $0.53 |
| 52 Week High | $2.05 | $3.07 |
Technical Indicators
Market Signals| Indicator | KLTR | IVVD |
|---|---|---|
| Relative Strength Index (RSI) | 56.92 | 37.35 |
| Support Level | $1.23 | $0.60 |
| Resistance Level | $1.53 | $1.02 |
| Average True Range (ATR) | 0.06 | 0.06 |
| MACD | 0.02 | -0.01 |
| Stochastic Oscillator | 95.14 | 9.53 |
Price Performance
Historical ComparisonAbout KLTR Kaltura Inc.
Kaltura Inc provides live and on-demand video SaaS solutions to thousands of organizations around the world, engaging hundreds of millions of viewers at home, at work, and at school. It also offers specialized industry solutions, including Learning Management System Video, Lecture Capture, and Virtual Classroom for educational institutions, as well as a TV Solution for media and telecom companies. It operates in two reporting segments which are Enterprise, Education, and Technology, and Media and Telecom. The majority of the revenue is derived from Enterprise, Education & Technology. The majority of the revenue is earned from the United States.
About IVVD Invivyd Inc.
Invivyd Inc is a biopharmaceutical company focused on the discovery, development, and commercialization of monoclonal antibody (mAb) therapies for the prevention and treatment of serious viral infectious diseases. Its lead product, PEMGARDA (pemivibart), received emergency use authorization from the U.S. FDA for the pre-exposure prevention of COVID-19 in certain immunocompromised individuals. The company is also developing next-generation antibody candidates, including VYD2311 for COVID-19 and VBY329 for RSV infections, while continuing research on additional antibodies targeting other viral diseases such as measles.